| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/13/2013 | US20130149242 Labeled Alginate Conjugates for Molecular Imaging Applications |
| 06/13/2013 | US20130149240 99mTc-LABELED TRIPHENYLPHOSPHONIUM DERIVATIVE CONTRASTING AGENTS AND MOLECULAR PROBES FOR EARLY DETECTION AND IMAGING OF BREAST TUMORS |
| 06/13/2013 | US20130149239 5-pyrrolidinylsulfonyl-isatin derivatives |
| 06/13/2013 | CA2853138A1 Therapeutic use of anti-cd22 antibodies for inducing trogocytosis |
| 06/12/2013 | EP2600904A1 Artificial cells |
| 06/12/2013 | CN103153350A Peptide radiotracer compositions |
| 06/12/2013 | CN103153349A Composition for treating liver cancer in humans based on rhenium-188 and method for preparing such a composition |
| 06/12/2013 | CN103145932A Long-circulating anti-tumor targeting drug carrier and preparation method thereof |
| 06/12/2013 | CN101432307B Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 06/11/2013 | US8460635 Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents |
| 06/11/2013 | CA2491484C Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 06/11/2013 | CA2442839C Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 06/06/2013 | WO2013082254A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| 06/06/2013 | WO2013081091A1 Drug for producing radiolabeled polypeptide reducing non-specific renal accumulation |
| 06/06/2013 | WO2013079496A1 Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (pet) imaging for lrrk2 |
| 06/06/2013 | US20130144035 Compositions and methods for leukocyte-targeting multi-valent imaging probes |
| 06/06/2013 | US20130143294 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 06/06/2013 | CA2857539A1 Bacteriophage gene 3 protein compositions and use as amyloid binding agents |
| 06/06/2013 | CA2856002A1 Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (pet) imaging for lrrk2 |
| 06/06/2013 | CA2855566A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| 06/06/2013 | CA2854194A1 Mmp-targeted therapeutic and/or diagnostic nanocarriers |
| 06/05/2013 | EP2599497A2 Porphyrazine-chemotherapeutic agents conjugates |
| 06/05/2013 | EP2598175A1 Radiopharmaceutical compositions |
| 06/05/2013 | CN101768208B Novel 18F-labelled polypeptide, preparation method and application thereof in tumor imaging |
| 06/04/2013 | US8455618 Melanocortin receptor-specific peptides |
| 06/04/2013 | US8455617 Melanocortin receptor-specific peptides |
| 06/04/2013 | US8454935 Cell permeable probe |
| 06/04/2013 | US8454934 High molecular weight chelation structure |
| 05/30/2013 | WO2013078250A2 Cystine knot peptides that bind alpha-v-beta-6 integrin |
| 05/30/2013 | US20130137975 Pet imaging |
| 05/30/2013 | US20130136696 Metallic nanoparticles with coated shells and applications of same |
| 05/30/2013 | US20130136691 Gastrin releasing peptide compounds |
| 05/30/2013 | US20130136690 Isotope preparation method |
| 05/29/2013 | EP2595666A1 Method of labelling a biologically active molecule with 5 - fluoro - 5 - deoxypentose or a 3 - fluoro - 3 - deoxypentose |
| 05/29/2013 | EP2595665A1 Bifunctional rho kinase inhibitor compounds, composition and use |
| 05/29/2013 | CN103120640A Embolic agent as well as preparation method and use method thereof |
| 05/29/2013 | CN102167728B 改进的胃泌素释放肽化合物 Improved gastrin-releasing peptide compounds |
| 05/29/2013 | CN101951964B Imaging method |
| 05/29/2013 | CN101878213B Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 05/28/2013 | US8449900 Pesticide strips for control of mites in honeybees |
| 05/28/2013 | US8449866 Cellular labeling for nuclear magnetic resonance techniques |
| 05/28/2013 | US8449863 Stabilized uncoated particles of reversed liquid crystalline phase materials |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/23/2013 | WO2013074583A1 Treatment and prognosis of lymphangioleiomyomatosis |
| 05/23/2013 | WO2013074531A1 Combination nutritional and nutraceutical products |
| 05/23/2013 | WO2013072526A1 Selective imaging of actin in live native cells |
| 05/23/2013 | US20130131327 Tricarbonyl Complexes with Tridentate Chelators for Myocardium Imaging |
| 05/23/2013 | US20130130295 Carbon nanotube based imaging agents |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | US20130129626 In vivo imaging agents |
| 05/23/2013 | US20130129625 In vivo imaging agents |
| 05/23/2013 | US20130129623 Radiopharmaceutical compositions |
| 05/23/2013 | US20130129622 Cyclopentapeptide derivatives and uses thereof |
| 05/23/2013 | US20130129621 Integrin Receptor Antagonists and Their Methods of Use |
| 05/23/2013 | US20130129620 Tricarbonyl Complexes with Tridentate Chelators for Myocardium Imaging |
| 05/23/2013 | US20130129619 Molecular Imaging of Cancer Cells In Vivo |
| 05/23/2013 | US20130129618 Egcg stabilized gold nanoparticles and method for making same |
| 05/23/2013 | US20130129617 Method for Treating Psoriatic Arthritis By Administering An Anti-IL-12 Antibody |
| 05/23/2013 | US20130129615 Methods, compositions and kits for providing a therapeutic treatment |
| 05/23/2013 | US20130129614 Microorganisms for imaging and/or treatment of tumors |
| 05/22/2013 | EP2594568A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 05/22/2013 | EP2594290A1 Selective imaging of actin in live native cells |
| 05/22/2013 | CN103118710A Apoptosis imaging agents based on lantibiotic peptides |
| 05/22/2013 | CN103113354A PEGylated benzyltriazolyl pyridazinone compounds, and preparation method and application thereof |
| 05/22/2013 | CN103110966A Fluoride-18 marked dopamine D4 receptor developing agent and preparation method thereof |
| 05/22/2013 | CN101854957B Radiofluorination methods |
| 05/21/2013 | US8445644 ErbB interface peptidomimetics and methods of use thereof |
| 05/21/2013 | US8445006 Biomolecular coating for implants |
| 05/21/2013 | US8445000 Immunogenic compositions of Staphylococcus epidermidis polypeptide antigens |
| 05/21/2013 | US8444983 Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases |
| 05/21/2013 | US8444957 Methods of screening for neoplastic disease states |
| 05/21/2013 | US8444956 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules |
| 05/21/2013 | US8444955 Radiofluorination methods |
| 05/21/2013 | US8444954 Gastrin releasing peptide compounds |
| 05/21/2013 | US8444953 Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof |
| 05/21/2013 | CA2478011C Bispecific antibody point mutations for enhancing rate of clearance |
| 05/17/2013 | CA2812885A1 Methods for the synthesis of 13c labeled iodotridecane and use as a reference standard |
| 05/16/2013 | WO2013070471A1 Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
| 05/16/2013 | US20130123471 Antibody Against Carcinoembryonic Antigen and Uses Thereof |
| 05/16/2013 | US20130121913 Anti-CD19 Antibodies |
| 05/16/2013 | US20130121912 Microrna-198 as a tumor suppressor in pancreatic cancer |
| 05/15/2013 | EP2591808A2 Selective radiolabeling of biomolecules |
| 05/15/2013 | EP2590683A1 Method for production of f-18 labeled amyloid beta ligands |
| 05/15/2013 | CN103108659A Radiopharmaceutical compositions |
| 05/15/2013 | CN103100094A Freeze-drying process applied to L-BPA |
| 05/15/2013 | CN101827614B Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 05/14/2013 | US8440168 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 05/14/2013 | US8440167 Multimodal imaging of atherosclerotic plaque targeted to LOX-1 |
| 05/14/2013 | CA2563692C Compositions and methods for enhancing contrast in imaging |
| 05/10/2013 | WO2013066181A1 Imaging ligands |
| 05/10/2013 | WO2013039308A3 A water-soluble fluorescence compound and method for preparing the same |
| 05/09/2013 | US20130115191 T cell receptor fusions and conjugates and methods of use thereof |
| 05/09/2013 | US20130115168 Catalytic Radiofluorination |
| 05/08/2013 | CN103096936A Imaging tuberculosis with pyrazinamide contrast agents |
| 05/08/2013 | CN101616692B Polychromatic, diversely-sized particles for angiography |
| 05/07/2013 | US8435993 Methods of inhibiting metastasis from cancer |
| 05/07/2013 | US8435960 Devices for improved wound management |
| 05/07/2013 | US8435539 Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
| 05/07/2013 | US8435493 Imaging agents |
| 05/07/2013 | US8435492 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals |